Meu P.

Meu P. is a skilled scientist specializing in antibody engineering, currently working at Neurocrine Biosciences since February 2023. Prior experience includes a PhD candidate role at the University of Michigan from September 2017 to January 2023, where significant contributions were made in the development of bispecific antibodies and the investigation of pharmacokinetics for brain-targeting antibodies, including novel discoveries related to SARS-CoV-2 neutralizing antibodies. Additionally, a co-op position at Biogen involved the co-design and expression of bispecific antibodies and Fc-fusion proteins, along with the study of their pharmacokinetics. Early research experience was gained at the Korea Advanced Institute of Science and Technology, focusing on drug delivery biomaterials. Meu P. holds a PhD in Pharmaceutical Sciences from the University of Michigan and has degrees in Biomaterials, Nanotechnology, and Drug Delivery from Korea Advanced Institute of Science and Technology and in Nano Engineering from Chulalongkorn University.